SEC Form 4 · accession 0001209191-18-002773
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis L Winger
Director
Period of report
Jan 4, 2018
Accepted (ET)
Jan 8, 2018 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2018 | M | 33,750 | $11.97 | A | 77,000 | D | |
| Common Stock | holding | — | — | — | 5,000 | I | by Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $11.97 | Jan 4, 2018 | M | 22,500 | D | Dec 8, 2012 | Jan 15, 2018 | Common Stock | 22,500 | 0 | D |
| Stock OptionF1 | $11.97 | Jan 4, 2018 | M | 11,250 | D | Sep 30, 2010 | Jan 15, 2018 | Common Stock | 11,250 | 0 | D |
Explanation of responses
- F1This transaction was made for stock options scheduled to expire on January 15, 2018.